Stock events for Nutex Health, Inc. (NUTX)
Nutex Health's stock has experienced significant movements over the past six months. As of October 24, 2025, the share price was $125.57, a 423.21% rise from $24.00 on October 28, 2024. The stock has shown volatility, with a 52-week high of $184.27 and a low of $21.55. Key events include an article highlighting strong performance and Q2 results on August 25, a financial reporting update on August 20, preliminary second-quarter results and a stock repurchase program announcement on August 14, a class action lawsuit announcement on August 26, a downgrade from "strong-buy" to "buy" by Wall Street Zen on October 18, and a restated "hold (C-)" rating by Weiss Ratings on October 26.
Demand Seasonality affecting Nutex Health, Inc.’s stock price
Specific details about the demand seasonality for Nutex Health's products and services are not explicitly stated in the provided snippets. The company operates emergency rooms and provides inpatient care, which typically experience consistent demand, though certain health conditions or seasonal illnesses might lead to fluctuations in patient volume.
Overview of Nutex Health, Inc.’s business
Nutex Health, Inc. operates in the Healthcare sector, focusing on Health Information Services. Its business is divided into Healthcare and Real Estate segments. The Healthcare segment offers a range of medical services, including emergency room care, inpatient care, behavioral health, and onsite imaging services, along with certified laboratories, inpatient pharmacies, and healthcare billing services. The Real Estate segment leases land and hospital buildings. The company also has a Population Health Management Division that refers patients to its hospitals and establishes a network of physicians.
NUTX’s Geographic footprint
Nutex Health owns and operates 21 facilities across 8 states. The company has expanded to 24 micro hospitals and hospital outpatient departments (HOPDs) in 11 states. The company is headquartered in Houston, Texas, where it was founded in 2011.
NUTX Corporate Image Assessment
Nutex Health received positive recognition with 20 awards and accolades in Q3 2025. The company's micro-hospital model delivering concierge-style care has been noted for high margins and profitability, and success in arbitration cases. However, the company's reputation was also impacted by a class action lawsuit filed against Nutex Health Inc., announced on August 26, 2025.
Ownership
Nutex Health Inc. is owned by a mix of institutional shareholders, insiders, and retail investors. Institutional shareholders hold 31.34% of the stock, Nutex Health insiders hold 30,862.80%, and retail investors hold 0.00%. Major institutional owners include Topline Capital Management, LLC, BlackRock, Inc., and Vanguard Group Inc. The largest individual shareholder is Thomas T. Vo, who owns 1.35 billion shares, representing 24,209.16% of the company.
Ask Our Expert AI Analyst
Price Chart
$131.71